Ocular Therapeutix Inc (OCUL)
10.27
-0.12
(-1.16%)
USD |
NASDAQ |
Nov 04, 16:00
10.24
-0.04
(-0.34%)
After-Hours: 20:00
Ocular Therapeutix Market Cap: 1.601B for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.601B |
| November 01, 2024 | 1.620B |
| October 31, 2024 | 1.642B |
| October 30, 2024 | 1.728B |
| October 29, 2024 | 1.762B |
| October 28, 2024 | 1.773B |
| October 25, 2024 | 1.737B |
| October 24, 2024 | 1.698B |
| October 23, 2024 | 1.693B |
| October 22, 2024 | 1.762B |
| October 21, 2024 | 1.773B |
| October 18, 2024 | 1.767B |
| October 17, 2024 | 1.729B |
| October 16, 2024 | 1.788B |
| October 15, 2024 | 1.595B |
| October 14, 2024 | 1.631B |
| October 11, 2024 | 1.525B |
| October 10, 2024 | 1.438B |
| October 09, 2024 | 1.450B |
| October 08, 2024 | 1.453B |
| October 07, 2024 | 1.478B |
| October 04, 2024 | 1.534B |
| October 03, 2024 | 1.439B |
| October 02, 2024 | 1.452B |
| October 01, 2024 | 1.413B |
| Date | Value |
|---|---|
| September 30, 2024 | 1.357B |
| September 27, 2024 | 1.353B |
| September 26, 2024 | 1.369B |
| September 25, 2024 | 1.378B |
| September 24, 2024 | 1.339B |
| September 23, 2024 | 1.319B |
| September 20, 2024 | 1.400B |
| September 19, 2024 | 1.410B |
| September 18, 2024 | 1.411B |
| September 17, 2024 | 1.366B |
| September 16, 2024 | 1.392B |
| September 13, 2024 | 1.403B |
| September 12, 2024 | 1.358B |
| September 11, 2024 | 1.316B |
| September 10, 2024 | 1.304B |
| September 09, 2024 | 1.304B |
| September 06, 2024 | 1.308B |
| September 05, 2024 | 1.316B |
| September 04, 2024 | 1.314B |
| September 03, 2024 | 1.302B |
| August 30, 2024 | 1.375B |
| August 29, 2024 | 1.335B |
| August 28, 2024 | 1.402B |
| August 27, 2024 | 1.410B |
| August 26, 2024 | 1.405B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
123.56M
Minimum
Nov 12 2019
1.788B
Maximum
Oct 16 2024
647.66M
Average
483.30M
Median
Market Cap Benchmarks
| Marinus Pharmaceuticals Inc | 18.46M |
| 4D Molecular Therapeutics Inc | 424.85M |
| Lyell Immunopharma Inc | 327.68M |
| NovaBay Pharmaceuticals Inc | 3.694M |
| Palatin Technologies Inc | 23.26M |
Market Cap Related Metrics
| PS Ratio | 19.89 |
| PEG Ratio | -0.6086 |
| Price to Book Value | 4.240 |
| Price | 10.27 |
| Earnings Yield | -13.15% |
| PEGY Ratio | -0.6086 |